Abstract
In a group of 22 autistic children aged 5 to 16 years and a group of normal controls matched for age and sex, catecholamines metabolism was investigated in plasma, platelets, and urine. This investigation was part of a research project in which several biological parameters (including serotonin) were explored simultaneously in the same children. In the autistic group, epinephrine and norepinephrine were significantly elevated in plasma, while epinephrine, norepinephrine, and dopamine were significantly lower in isolated platelets. No significant difference was found between the two groups for the urinary excretion of epinephrine, norepinephrine, dopamine, DOPAC, and MHPG. Other differences between the two groups in the statistical correlations of several biochemical parameters also suggest abnormalities of bioamine metabolism in the platelets of autistic children.
This is a preview of subscription content, access via your institution.
References
Bellmaker, R. H., Hattab, J., & Ebstein, R. P. (1978). Plasma dopamine-beta-hydroxylase in childhood psychosis.Journal of Autism and Childhood Schizophrenia, 8, 293–298.
Boullin, D. J., & O'Brien, R. A. (1972). Uptake and loss of 14C-dopamine by platelets from children with infantile autism.Journal of Autism and Childhood Schizophrenia, 2, 67–74.
Boullin, D. J., Bhagavan, H. N., O'Brien, R. A., & Youdim, M. B. H. (1976). Platelet monoamine oxidase in children with infantile autism. In M. Coleman (Ed.),The autistic syndromes (pp. 51–63). Amsterdam: North Holland.
Campbell, M., Friedman, E., Green, W. H., Small, A. M., & Burdock, E. I. (1976). Blood platelet monoamine oxidase activity in schizophrenic children and their families.Neuropsychobiology, 2, 239–246.
Cohen, D. J., Shaywitz, B. A., Johnson, W. K., & Bowers, M. (1974). Biogenic amines in autistic and atypical children: cerebrospinal fluid measure of homovanillic acid and 5-hydroxy indole acetic acid.Archives of General Psychiatry, 31, 845–853.
Cohen, D. J., Caparulo, B. K., Shaywitz, B. A., & Bowers, M. B. (1977a). Dopamine and serotonin metabolism in neuropsychiatrically disturbed children.Archives of General Psychiatry, 34, 545–550.
Cohen, D. J., Young, J. G., & Roth, J. A. (1977b). Platelet monoamine oxidase in early childhood autism.Archives of General Psychiatry, 34, 534–537.
Costa, J. L., Stark, H., Shafer, B., Corash, L., Smith, M. A., & Murphy, D. L. (1978). Maximal packet size for serotonin in storage vesicles of intact human platelets.Life Sciences, 23, 2193–2197.
Da Prada, M., & Zurcher, G. (1979). Radioenzymatic assay of plasma and urinary catecholamines in man and various animal species: physiological and pharmacological applications. In A. Albertini, M. Da Prada, & B. A. Pesker (Eds.)Radioimmunoassay of drugs and hormones in cardiovascular medicine (pp. 175–198). Amsterdam: Elsevier.
Da Prada, M., Richards, J. G., & Kettler, R. (1981). Amine storage organelles in platelets. In J. L. Gordon (Ed.),Platelets in biology and pathology (Vol. 2, pp. 107–145). Amsterdam: Elsevier.
De Villard, R., & Dalery J. (1979). A propos de quelques données concernant l'élimination urinaire de dérivés méthylés des catécholamines chez les enfants porteurs de psychose infantile á forme autistique précoce. Hypothéses de travail.Annals Medico Psychologiques, 137, 109–114.
Feldman, J. M., & Davis, J. A. (1981). Radioenzymatic assay of platelet serotonin, dopamine, and norepinephrine in subjects with normal and increased serotonin production.Clinical Chimica Acta, 109, 275–283.
Ferrari, P., Bursztejn, C., Braconnier, A., Zarifian, E., Launay, J. M., & Dreux, C. (1985, September). Metabolism of serotonin in autistic children.Fourth World Congress of Biological Psychiatry, Philadelphia. (Abstract No. 132.3, p. 61).
Gadd, R. E. A., & Clayman, S. (1972). A reassesment of the use of modified Tyrode's solution as a physiological medium for suspension of isolated platelets.Experientia, 28, 719–720.
Garnier, C., Barthelemy, C., Garreau, B., Jouve, J., Muh, J. P., & Lelord, G. (1983). Les anomalies des monoamines et de leurs enzymes dans l'autisme de l'enfant.L'Encéphale, 9, 201–262.
Garnier, C., Comoy, E., Barthelemy, C., Leddet, I., Garreau, B., Muh, J. P., & Lelord, G. (1986). Dopamine-β-hydroxylase (DBH) and homovanilic acid (HVA) in autistic children.Journal of Autism and Developmental Disorders, 16, 23–29.
Gillberg, C., Svennerholm, L., & Hamilton-Hellberg, C. (1983). Childhood psychosis and monoamine metabolites in spinal fluid.Journal of Autism and Developmental Disorders, 13, 383–396.
Goldstein, M., Manahand, D., Lee J., & Coleman, M. (1976). Dopamine-β-hydroxylase and endogenous total 5-hydroxy indoles levels in autistic patients and controls. In M. Coleman (Ed.),The autistic syndromes (pp. 57–63). Amsterdam: North Holland.
Hanley, H. G., Stahl, S. M., & Freedman, D. X. (1977). Hyperserotoninemia and amine metabolites in autistic and retarded children.Archives of General Psychiatry, 34, 521–531.
Krstulovic, A. M. (1982). Investigations of catecholamine metabolism using high-performance liquid chromatography. Analytical methodology and clinical applications.Journal of Chromatography, 229, 1–34.
Kuffer, H., Takkinen, R., & Jaag, R. (1975). Die direkte Bestimmung des Creatinins in Plasma, Serum und Urine: Störung durch Bilirubin (abstract).Zeitschrift for Klinische Chemie und Klinische Biochemic, 13, 244.
Lake, L. R., Ziegler, M. G., & Murphy, D. L. (1977). Increased norepinephrine levels and decreased dopamine-beta-hydoxylase activity in primary autism.Archives of General Psychiatry, 34, 553–556.
Landgrebe, A. R., & Landgrebe, M. A. (1976). Urinary catecholamine screening in autistic children. In M. Coleman (Ed.),The autistic syndromes (pp. 65–71). Amsterdam: North Holland.
Launay, J. M., Ferrari, P., Bursztejn, C., Haimart, M., Braconnier, A., Luong, C. L., & Dreux, C. (Submitted). Reappraisal of serotonin metabolism in autistic children.
Leckman, J. F., Cohen, D. J., Shaywitz, B. A., Caparulo, B. K., Heninger, G. R., & Bowers, M. B. (1980). CSF monoamine metabolites in child and adult psychiatric patients. A developmental perspective.Archives of General Psychiatry, 37, 677–681.
Lelord, G., Callaway, E., Muh, J. P., Arlot, J. C., Sauvage, D., Garreau, B., & Domenech, J. (1978). L'acide homovanilique urinaire et ses modifications par injections de vitamine B6: exploration fonctionnelle dans l'autisme de l'enfant.Revue Neurologique, 134, 797–801.
Lowry, O. H., Rosebrough, N. J., Farr, A. L., & Randall, R. J. (1951). Protein measurement with the Folin phenol reagent.Journal of Biological Chemistry, 193, 265–275.
Murphy, D. L., Wright, C., Buchsbaum, M., Nichols, A., Costa, J. L., & Wyatt, R. J. (1976). Platelet and plasma amine oxidase activity in 680 normals: Sex and age differences and stability over time.Biochemical Medicine, 16, 254–265.
Omenn, G. S., & Smith, C. T. (1978). A common uptake system for serotonin and dopamine in human platelets.Journal of Clinical Investigation, 62, 235–240.
Pletscher, A., Affolter, H., Cesura, A. M., Erne, P., & Muller, K. (1984). Blood platelets as models for neurons: similarities of the 5-hydroxytryptamine systems. In H. C. Schlossberger, W., Kochen, B. Linzen, H. Steinhart (Eds.),Progress in tryptophan and serotonin research (pp. 231–239). Berlin, W. de Gruyter.
Redmond, D. E., & Huang, Y. H. (1979). New evidence for a locus coeruleus-norepinephrine connection with anxiety.Life Sciences, 25, 2149–2162.
Sedvall, G., Fyro, B., Gullberg, B., Nyback, H., Wiesel, F. A., & Wode-Helgodt, B. (1980). Relationships in healthy volunteers between concentration of monoamine metabolities in cerebrospinal fluid and family history of psychiatric morbidity.British Journal of Psychiatry, 136, 366–374.
Siegel, S. (1956).Nonparametric statistics for the behavioral sciences. New York: McGraw Hill.
Stahl, S. M. (1977). The human platelet. A diagnostic and research tool for the study of biogenic amines in psychiatric and neurologic disorders.Archives of General Psychiatry, 34, 509–516.
Tassin, J. P. (1980). Approche du röle fonctionnel du système méso-cortical dopaminergique.Psychologie Medicale, 12, 43–62.
Tukey, J. W. (1977).Exploratory data analysis. Philippines: Addison-Wesley.
Young, J. G., Cohen, D. J., Brown, S. L., & Caparulo, B. K. (1978). Decreased urinary free catecholamins in childhood autism.Journal of the American Academy of Child Psychiatry, 17, 671–678.
Young, J. G., Cohen, D. J., Caparulo, B. K., Brown, S. L., & Maas, J. W. (1979). Decreased 24-hour urinary MHPG in childhood autism.American Journal of Psychiatry, 136, 1055–1057.
Young, J. G., Kyprie, R. M., Ross, N. T., & Cohen, D. J. (1980). Serum dopamine-beta-hydroxylase activity: clinical applications in child psychiatry.Journal of Autism and Developmental Disorders, 10, 1–14.
Young, J. G., Cohen, D. J., Kavanagh, M. E., Landis, H. D., Shaywitz, B. A., & Maas, J. W. (1981). Cerebrospinal fluid, plasma and urinary MHPG in children.Life Sciences, 28, 2837–2845.
Young, J. G., Kavanagh, M. E., Anderson, G. M., Shaywitz, B. A., & Cohen, D. J. (1982). Clinical neurochemistry of autism and associated disorders.Journal of Autism and Developmental Disorders, 12, 147–165.
Author information
Authors and Affiliations
Additional information
This work was supported by a grant of the Institut National de la Santé et de la Recherche Médicale (INSERM-ATP n∘ 73.79.105). We are indebted to Prof. M. Da Prada, Pharmaceutical Research Department, Hoffman-La Roche, Basel, for his continuous help throughout this work, and to Ms. D. Pasques, Hôpital Saint-Louis, Paris, for her excellent technical assistance.
Rights and permissions
About this article
Cite this article
Launay, J.M., Bursztejn, C., Ferrari, P. et al. Catecholamines metabolism in infantile autism: A controlled study of 22 autistic children. J Autism Dev Disord 17, 333–347 (1987). https://doi.org/10.1007/BF01487064
Issue Date:
DOI: https://doi.org/10.1007/BF01487064